Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Vesprini

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Frontiers in Oncology|September 22, 2022
Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technologyWilliam A Hall, Amar U Kishan, Emma Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2025
Bowel bag dosimetric parameters for ultrahypofractionated pelvic elective nodal irradiation in prostate cancerWee Loon Ong, Melanie Davidson, Matt Wronski, et al.
European Urology|July 7, 2009
No role for routine chest radiography in stage I seminoma surveillanceShaun Tolan, Danny Vesprini, Michael A S Jewett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancerRobert K Nam, William W Zhang, John Trachtenberg, et al.
The Journal of Urology|January 22, 2019
Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 YearsKeyan Salari, David Kuppermann, Mark A Preston, et al.
European Urology|November 12, 2019
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-upLaurence Klotz, Greg Pond, Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
Radiation Oncology (London, England)|February 8, 2023
Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experienceDaniel Moore-Palhares, Ling Ho, Lin Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy BoostHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of lifeHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Oncology|September 22, 2022
Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technologyWilliam A Hall, Amar U Kishan, Emma Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|August 17, 2025
Bowel bag dosimetric parameters for ultrahypofractionated pelvic elective nodal irradiation in prostate cancerWee Loon Ong, Melanie Davidson, Matt Wronski, et al.
European Urology|July 7, 2009
No role for routine chest radiography in stage I seminoma surveillanceShaun Tolan, Danny Vesprini, Michael A S Jewett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancerRobert K Nam, William W Zhang, John Trachtenberg, et al.
The Journal of Urology|January 22, 2019
Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 YearsKeyan Salari, David Kuppermann, Mark A Preston, et al.
European Urology|November 12, 2019
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-upLaurence Klotz, Greg Pond, Andrew Loblaw, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
Radiation Oncology (London, England)|February 8, 2023
Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experienceDaniel Moore-Palhares, Ling Ho, Lin Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2021
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy BoostHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2021
Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of lifeHima Bindu Musunuru, Patrick Cheung, Danny Vesprini, et al.
Pageof 15